Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 276-057-2 | CAS number: 71832-85-4
Endpoint summary
Administrative data
Description of key information
Four studies were performed to evaluate acute oral and dermal toxicity of the test substance and a structural analogue to the rat (according or similar to OECD 401, 402). Neither the test substance nor the analogue induces any mortalities, abnormalities or clinical signs when applied oral or dermal. The LD50 for oral and dermal toxicity is considered to be > 5000 mg/kg bw and > 2000 mg/kg bw, respectively.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
- Remarks:
- no details to test item, some data concerning animals (breeder, acclimatization period) and enviromental conditions (humidity and air changes7h) are missing, frequency of observation not given, no details to autopsy result or any individual data
- Qualifier:
- equivalent or similar to
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- GLP compliance:
- not specified
- Test type:
- standard acute method
- Limit test:
- yes
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: /
- Age at study initiation: 5-6 weeks
- Weight at study initiation: 113 g male and 131 g female
- Fasting period before study: 18h
- Housing: singly
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): ad libitum
- Acclimation period: /
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21 +/- 2
- Humidity (%): /
- Air changes (per hr): /
- Photoperiod (hrs dark / hrs light): 12
IN-LIFE DATES: From: To: - Route of administration:
- oral: gavage
- Vehicle:
- CMC (carboxymethyl cellulose)
- Remarks:
- 2 % aqueous solution
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: 25%
- Amount of vehicle (if gavage): 20 ml/kg bw
MAXIMUM DOSE APPLIED: 5000 mg/kg bw - Doses:
- 5000 mg/kg bw
- No. of animals per sex per dose:
- 5 per sex and dose
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: /
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs and autopsy - Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 5 000 mg/kg bw
- Mortality:
- no
- Clinical signs:
- no
- Gross pathology:
- no findings
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- The acute oral median lethal dose (LD50) in rats is greater than 5 g/kg bw. Therefore, no indication for acute toxicity is indicated.
- Executive summary:
The test substance was tested for its acute toxicity potential in the standard acute test method, similar to OECD 401.
Five male and female Sprague-Dawley rats were individually housed. The test substance was administered in a carboxymethyl cellulose vehicle as a limit dose of 5000 mg/kg bw.
Animals were observed for clinical signs and an autopsy was performed at the end of the 14 day observation period.
There were no clinical symptoms observed and no animal died during the study. At autopsy no changes in organs or tissues caused by the administration of the test compound were seen.
The acute oral median lethal dose (LD50) was greater than 5 g/kg body weight and the test substance is not considered acute toxic in rats.
Reference
No clinical symptoms were recorded and no deaths occurred during the 14 day observation period. At autopsy no changes in organs or tissues caused by the administration of the test compound were seen.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 5 000 mg/kg bw
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Justification for type of information:
- Further information are included as attachment in chapter 13 of the IUCLID dossier.
- Reason / purpose:
- read-across source
- Reason / purpose:
- read-across: supporting information
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Interpretation of results:
- GHS criteria not met
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
Additional information
Acute oral toxicity
The test substance was tested for its acute toxicity potential in the standard acute test method, similar to OECD 401.
Five male and female Sprague-Dawley rats were individually housed. The test substance was administered in a carboxymethyl cellulose vehicle as a limit dose of 5000 mg/kg bw.
Animals were observed for clinical signs and an autopsy was performed at the end of the 14 day observation period.
There were no clinical symptoms observed and no animal died during the study. At autopsy no changes in organs or tissues caused by the administration of the test compound were seen.
The acute oral median lethal dose (LD50) was greater than 5 g/kg body weight and the test substance is not considered acute toxic in rats.
In one acute toxicity tests in structurally analog substances in male and female Sprague-Dawley and Wistar rats, similar to OECD 401, no death occurred up to 15000 mg/kg bw.
Acute dermal toxicity
There are two acute dermal toxicity tests with structurally analog substances according to or similar to OECD 402 with male and female Wistar rats. The test substance was administered up to limit concentrations of 2000 and 5000 mg/kg bw.
No animals died during the study periods.
Justification for classification or non-classification
The available experimental test data are reliable and suitable for classification purposes under Regulation 1272/2008, as amended for the thirteenth time in Regulation (EU) No 2018/1480. As a result the substance is not considered to be classified for acute toxicity under Regulation (EC) No. 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Route: .live2